Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 3

T Cells in Cancer II

Thursday, April 16, 2026
8:00 AM - 9:30 AM US ET
Location: 157

Presentations:

  • 8:00 AM - 8:15 AM US ET
    The BMP-KLF3 circuit promotes resilient programming in CD8+ T cells during chronic infection and cancer

    Author: Abbey Saadey (she/her/hers) – Ohio State University

  • 8:15 AM - 8:30 AM US ET
    HuR–SerpinB9 Axis Regulates Tumor T-Cell Fitness and Persistence via Post-Transcriptional Control

    Author: Paramita Chakraborty (she/her/hers) – Medical University of South Carolina

  • 8:45 AM - 9:00 AM US ET
    Spatial IgA Plasma Cell Niches Drive Anti-Tumor Immunity in Pancreatic Cancer

    Author: Lily Liu (she/her/hers) – Augusta University

  • 9:00 AM - 9:15 AM US ET
    CAR-T with ICOS costimulation lacks therapeutic efficacy in patients due to strong trogocytosis and failure of expansion

    Author: Yongxia Wu, MD, PhD (she/her/hers) – Medical College of Wisconsin

  • 9:15 AM - 9:30 AM US ET
    Burn Baby Burn: Leveraging Fatty Acid Oxidation to Improve CD8+ T cell Efficacy Against Ovarian Cancer.

    Author: Emily-Claire K. Duffy (she/her/hers) – Dartmouth College